Healthcare - Biotechnology - NASDAQ - DK
$ 1.44
-14.3 %
$ 8.16 M
Market Cap
-0.51
P/E
CASH FLOW STATEMENT
-17.7 M
OPERATING CASH FLOW
-93 K
INVESTING CASH FLOW
10.7 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Evaxion Biotech A/S
| Net Income | -22.1 M |
| Depreciation & Amortization | 616 K |
| Capital Expenditures | -87 K |
| Stock-Based Compensation | 479 K |
| Change in Working Capital | 1.56 M |
| Others | 2.71 M |
| Free Cash Flow | -17.8 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||
| Net Income | (22.1) | (23.2) | (24.5) | (15.0) | (11.2) | (5.5) |
| Depreciation & Amortization | 0.6 | 0.6 | 0.3 | 0.1 | 81 K | 74 K |
| Deferred Income Tax | (1.0) | (1.0) | (0.2) | (2.1) | (0.8) | (0.7) |
| Stock Based Compensation | 0.5 | 0.9 | 1.4 | 3.4 | 2.4 | 2.1 |
| Other Operating Activities | 2.8 | (0.2) | (0.2) | 0.9 | 2.0 | 1.2 |
| Change in Working Capital | 1.6 | (2.9) | 1.2 | 0.2 | 0.6 | 1.0 |
| Cash From Operations | (17.7) | (25.8) | (21.9) | (12.4) | (7.0) | (2.0) |
| INVESTING CASH FLOW | ||||||
| Capital Expenditures | 87 K | (0.3) | (1.4) | (0.4) | 61 K | 7 K |
| Other Items | 6 K | 24 K | 30 K | 0 | 0 | 13 K |
| Cash From Investing Activities | 93 K | (0.3) | (1.3) | (0.4) | 61 K | 6 K |
| FINANCING CASH FLOW | ||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | (0.6) | 7.4 | (0.3) | 0 | 79 K | 7.9 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 2.2 | 0 | (3.8) | (0.2) | 13 K | 0 |
| Cash From Financing Activities | 10.7 | 7.9 | 49.8 | 8.8 | 9.5 | 9.0 |
| CHANGE IN CASH | ||||||
| Net Change In Cash | (7.6) | (19.0) | 26.3 | (3.7) | 2.1 | 7.0 |
| FREE CASH FLOW | ||||||
| Free Cash Flow | (17.8) | (26.1) | (23.3) | (12.8) | (7.1) | (2.0) |